Michael Spoganetz
About Michael Spoganetz
Michael Spoganetz is a Clinical Site Manager at Bristol-Myers Squibb in New York, with over 15 years of experience in clinical research and project management.
Company
Currently, Michael Spoganetz works at Bristol-Myers Squibb based in New York, New York, United States. He has been with the company for over a decade, starting in 2011. Bristol-Myers Squibb is known for its contributions to bio-pharmaceuticals, focusing on discovering and delivering innovative medicines that help patients prevail over serious diseases.
Title
Michael Spoganetz holds the title of Clinical Site Manager at Bristol-Myers Squibb. In this role, he is responsible for overseeing clinical trial sites, ensuring that trials are conducted according to regulatory requirements and study protocols.
Education and Expertise
Michael Spoganetz earned a Bachelor of Arts degree from Arcadia University, where he studied from 2004 to 2008. He furthered his education at Mercer County Community College between 2009 and 2010. With over 15 years of experience in clinical research and project management, his educational background supports his extensive professional expertise.
Background
Before his current role, Michael Spoganetz started his career at RadPharm, where he worked as a Senior Project Coordinator and Project Leader from 2008 to 2011. At Bristol-Myers Squibb, he initially served as a Senior Clinical Trial Associate for two years before transitioning to the role of Clinical Site Manager. His career reflects a solid progression in clinical research and project management, solidifying his expertise in the field.
Achievements
Throughout his career, Michael Spoganetz has accumulated significant experience in clinical research and project management. His transition from roles such as Senior Clinical Trial Associate to Clinical Site Manager demonstrates a strong upward trajectory in his professional journey. His over a decade-long tenure at Bristol-Myers Squibb highlights his commitment and depth of experience in clinical trial management.